96 related articles for article (PubMed ID: 18276090)
1. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis.
Jang SW; Lee JW; Park SH; Kim JH; Yoo M; Na DH; Lee KC
Int J Pharm; 2008 May; 356(1-2):88-94. PubMed ID: 18276090
[TBL] [Abstract][Full Text] [Related]
2. In vivo gastric residence and gastroprotective effect of floating gastroretentive tablet of DA-9601, an extract of Artemisia asiatica, in beagle dogs.
Kim JS; Cha KH; Kang SY; Won D; Jang SW; Son M; Son MH; Choi HJ; Lee YW; Kang MJ
Drug Des Devel Ther; 2016; 10():1917-25. PubMed ID: 27354765
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine.
Bandari S; Eaga CM; Thadishetty A; Yamsani MR
Acta Pharm; 2010 Mar; 60(1):89-97. PubMed ID: 20228043
[TBL] [Abstract][Full Text] [Related]
5. Sustained delivery of captopril from floating matrix tablets.
Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
[TBL] [Abstract][Full Text] [Related]
6. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori.
Patel SS; Ray S; Thakur RS
Acta Pol Pharm; 2006; 63(1):53-61. PubMed ID: 17515330
[TBL] [Abstract][Full Text] [Related]
7. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
8. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
9. Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe.
Li XD; Pan WS; Nie SF; Wu LJ
J Control Release; 2004 May; 96(3):359-67. PubMed ID: 15120893
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate.
Baki G; Bajdik J; Pintye-Hódi K
J Pharm Biomed Anal; 2011 Mar; 54(4):711-6. PubMed ID: 21109379
[TBL] [Abstract][Full Text] [Related]
11. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
12. Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber.
Lee TH; Choi JJ; Kim DH; Choi S; Lee KR; Son M; Jin M
Phytomedicine; 2008 Oct; 15(10):836-43. PubMed ID: 18490147
[TBL] [Abstract][Full Text] [Related]
13. Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients based approach.
Zaman M; Akhtar F; Baseer A; Hasan SMF; Aman W; Khan A; Badshah M; Majeedullah -
Pak J Pharm Sci; 2021 Jan; 34(1):57-63. PubMed ID: 34248003
[TBL] [Abstract][Full Text] [Related]
14. Hollow microspheres of diclofenac sodium - a gastroretentive controlled delivery system.
Bv B; R D; S B; Abraham S; Furtado S; V M
Pak J Pharm Sci; 2008 Oct; 21(4):451-4. PubMed ID: 18930869
[TBL] [Abstract][Full Text] [Related]
15. [Formula screening and optimizing for the dispersible tablets of breviscapine by orthogonal experiment].
Ding Y; Huang GH
Zhong Yao Cai; 2010 Mar; 33(3):455-8. PubMed ID: 20681316
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
[TBL] [Abstract][Full Text] [Related]
17. Development and potential application of an oral ColoPulse infliximab tablet with colon specific release: A feasibility study.
Maurer JM; Hofman S; Schellekens RC; Tonnis WF; Dubois AO; Woerdenbag HJ; Hinrichs WL; Kosterink JG; Frijlink HW
Int J Pharm; 2016 May; 505(1-2):175-86. PubMed ID: 26997425
[TBL] [Abstract][Full Text] [Related]
18. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
[TBL] [Abstract][Full Text] [Related]
19. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
20. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
